A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma
Phase 1/2 Completed
47 enrolled 36 charts
A Study of Avapritinib in Pediatric Patients With Solid Tumors Dependent on KIT or PDGFRA Signaling
Phase 1/2 Completed
29 enrolled
Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma
Phase 1/2 Completed
55 enrolled
BMX-HGG
Phase 1/2 Completed
177 enrolled 34 charts
MK-3475 in Combination With MRI-guided Laser Ablation in Recurrent Malignant Gliomas
Phase 1/2 Completed
55 enrolled 14 charts
H3.3K27M Peptide Vaccine With Nivolumab for Children With Newly Diagnosed DIPG and Other Gliomas
Phase 1/2 Completed
50 enrolled 12 charts
NIVOGLIO
Phase 1/2 Completed
41 enrolled
A Phase I/IIa Study of Cerebraca Wafer Plus Adjuvant Temozolomide (TMZ) in Patients With Recurrent High Grade Glioma
Phase 1/2 Completed
22 enrolled
Autologous Dendritic Cells, Metronomic Cyclophosphamide and Checkpoint Blockade in Children With Relapsed HGG
Phase 1/2 Completed
24 enrolled
Effect of Perampanel on Peritumoral Hyperexcitability in HGG
Phase 1/2 Completed
12 enrolled 8 charts
A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas
Phase 1/2 Completed
36 enrolled
Phase 1/2a Study of Oral BAL101553 in Adult Patients With Solid Tumors or Glioblastoma or High-grade Glioma
Phase 1/2 Completed
72 enrolled 30 charts
Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors
Phase 1/2 Completed
160 enrolled 21 charts
A Study of the Specificity and Sensitivity of 5- Aminolevulinic Acid (ALA) Fluorescence in Malignant Brain Tumors
Phase 1/2 Completed
33 enrolled 15 charts
A Study of BBI608 in Combination With Temozolomide in Adult Patients With Recurrent or Progressed Glioblastoma
Phase 1/2 Completed
34 enrolled 18 charts
Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including Central Nervous System Tumors
Phase 1/2 Completed
64 enrolled 29 charts
Autologous CMV-Specific Cytotoxic T Cells and Temozolomide in Treating Patients With Glioblastoma
Phase 1/2 Completed
65 enrolled 21 charts
Phase I/II Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma
Phase 1/2 Completed
12 enrolled 11 charts
A Phase 1/2A Study of LAM561 in Adult Patients With Advanced Solid Tumours
Phase 1/2 Completed
54 enrolled
Stage 1: Marizomib + Bevacizumab in WHO Gr IV GBM; Stage 2: Marizomib Alone; Stage 3: Combination of Marizomib and Bevacizumab
Phase 1/2 Completed
121 enrolled 27 charts
A Study of DSP-7888 in Pediatric Patients With Relapsed or Refractory High Grade Gliomas
Phase 1/2 Completed
18 enrolled
Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain Tumors
Phase 1/2 Completed
33 enrolled
Study of Orally Administered Enasidenib (AG-221) in Adults With Advanced Solid Tumors, Including Glioma, or Angioimmunoblastic T-cell Lymphoma, With an IDH2 Mutation
Phase 1/2 Completed
21 enrolled 33 charts
Proton Beam Radiation Therapy in Treating Patients With Low Grade Gliomas
Phase 1/2 Completed
23 enrolled
Study Evaluating ABT-414 in Japanese Subjects With Malignant Glioma
Phase 1/2 Completed
53 enrolled
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase 1/2 Completed
64 enrolled 11 charts
RAMBO
Phase 1/2 Completed
22 enrolled 18 charts
Phase I Trial of Intramural Injection of DTI-015 for Recurrent Malignant Gliomas
Phase 1/2 Completed
39 enrolled
Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma
Phase 1/2 Completed
30 enrolled 11 charts
SONOCLOUD
Phase 1/2 Completed
27 enrolled
Phase I/II Adaptive Randomized Trial of Bevacizumab Versus Bevacizumab Plus Vorinostat in Adults With Recurrent Glioblastoma
Phase 1/2 Completed
96 enrolled 15 charts
Irinotecan in Treating Patients With Progressive or Recurrent Malignant Glioma
Phase 1/2 Completed
SU5416 in Treating Patients With Recurrent Astrocytoma or Mixed Glioma That Has Not Responded to Radiation Therapy
Phase 1/2 Completed
Imatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or Meningioma
Phase 1/2 Completed
105 enrolled
CCI-779 in Treating Patients With Malignant Glioma
Phase 1/2 Completed
49 enrolled
Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme
Phase 1/2 Completed
116 enrolled 17 charts
Vaccination-Dendritic Cells With Peptides for Recurrent Malignant Gliomas
Phase 1/2 Completed
22 enrolled 8 charts
Safety and Efficacy of Trans Sodium Crocetinate (TSC) With Radiation and Temozolomide in Newly Diagnosed Glioblastoma
Phase 1/2 Completed
59 enrolled 10 charts
Veliparib and Temozolomide in Treating Patients With Recurrent Glioblastoma
Phase 1/2 Completed
257 enrolled 16 charts
LBH589 and Bevacizumab in Patients With Recurrent High Grade Glioma
Phase 1/2 Completed
51 enrolled 18 charts
A Study Combining LY2157299 With Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Glioma
Phase 1/2 Completed
75 enrolled
INTRAGO-Intraoperative Radiotherapy for Glioblastoma - a Phase I/II Study
Phase 1/2 Completed
12 enrolled
Magnetic Resonance Spectroscopic Imaging (MRS) and Tumor Perfusion of Human Glioblastoma Treated With Concurrent Radiation Therapy and Temozolomide
Phase 1/2 Completed
26 enrolled
Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma
Phase 1/2 Completed
69 enrolled 12 charts
An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma.
Phase 1/2 Completed
84 enrolled
Interstitial Infusion of IL13-PE38QQR Cytotoxin in Recurrent Malignant Glioma
Phase 1/2 Completed
60 enrolled
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Tumors
Phase 1/2 Completed
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Cancers
Phase 1/2 Completed
Study of NPC-08 is to Treat for Newly-Diagnosed Malignant Glioma and Recurrent Glioblastoma Multiforme
Phase 1/2 Completed
24 enrolled
Immunotoxin Therapy in Treating Patients With Malignant Glioma
Phase 1/2 Completed